• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Methodologies in Biosimilar Product Development

Methodologies in Biosimilar Product Development

Hardcover

Series: Chapman & Hall/CRC Biostatistics

Medical ReferenceProbability & Statistics

ISBN10: 0367896346
ISBN13: 9780367896348
Publisher: Crc Pr Inc
Published: Sep 24 2021
Pages: 380
Weight: 1.60
Height: 0.88 Width: 6.14 Depth: 9.21
Language: English

Methodologies for Biosimilar Product Development covers the practical and challenging issues that are commonly encountered during the development, review, and approval of a proposed biosimilar product. These practical and challenging issues include, but are not limited to the mix-up use of interval hypotheses testing (i.e., the use of TOST) and confidence interval approach, a risk/benefit assessment for non-inferiority/similarity margin, PK/PD bridging studies with multiple references, the detection of possible reference product change over time, design and analysis of biosimilar switching studies, the assessment of sensitivity index for assessment of extrapolation across indications without collecting data from those indications not under study, and the feasibility and validation of non-medical switch post-approval.

1 different editions

Also available

Also in

Probability & Statistics